PL1808442T3 - Enzymatyczna synteza glikokoniugatów mucyny na dużą skalę i ich zastosowanie immunogenne - Google Patents
Enzymatyczna synteza glikokoniugatów mucyny na dużą skalę i ich zastosowanie immunogenneInfo
- Publication number
- PL1808442T3 PL1808442T3 PL06290091T PL06290091T PL1808442T3 PL 1808442 T3 PL1808442 T3 PL 1808442T3 PL 06290091 T PL06290091 T PL 06290091T PL 06290091 T PL06290091 T PL 06290091T PL 1808442 T3 PL1808442 T3 PL 1808442T3
- Authority
- PL
- Poland
- Prior art keywords
- mucin
- glyconjugates
- scale synthesis
- applications
- immunogenic
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title 1
- 230000002255 enzymatic effect Effects 0.000 title 1
- 230000002163 immunogen Effects 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- 230000028993 immune response Effects 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4727—Mucins, e.g. human intestinal mucin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001169—Tumor associated carbohydrates
- A61K39/00117—Mucins, e.g. MUC-1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Transplantation (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06290091A EP1808442B1 (en) | 2006-01-13 | 2006-01-13 | Enzymatic large-scale synthesis of mucin glyconjugates, and immunogenic applications thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1808442T3 true PL1808442T3 (pl) | 2011-12-30 |
Family
ID=36160509
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL06290091T PL1808442T3 (pl) | 2006-01-13 | 2006-01-13 | Enzymatyczna synteza glikokoniugatów mucyny na dużą skalę i ich zastosowanie immunogenne |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US9657074B2 (pl) |
| EP (1) | EP1808442B1 (pl) |
| JP (1) | JP5231247B2 (pl) |
| AT (1) | ATE509027T1 (pl) |
| CA (1) | CA2631582C (pl) |
| ES (1) | ES2366552T3 (pl) |
| PL (1) | PL1808442T3 (pl) |
| WO (1) | WO2007079783A1 (pl) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008007941A1 (en) * | 2006-07-10 | 2008-01-17 | Vereniging Voor Christelijk Wetenschappelijk Onderwijs | Gainac specific binding molecules and uses thereof |
| KR20110039220A (ko) | 2008-06-30 | 2011-04-15 | 교와 핫꼬 기린 가부시키가이샤 | 항ｃｄ27 항체 |
| WO2011054359A2 (en) | 2009-11-06 | 2011-05-12 | University Of Copenhagen | Method for early detection of cancer |
| EP2520589B1 (en) * | 2009-12-29 | 2018-11-07 | Kyowa Hakko Kirin Co., Ltd. | Anti-cd27 antibody |
| CN102296052B (zh) * | 2011-08-17 | 2013-04-10 | 上海交通大学 | 一种针对ppGalNAc-T13多克隆抗体的特异性抗原肽及其制备与应用 |
| WO2013151649A1 (en) | 2012-04-04 | 2013-10-10 | Sialix Inc | Glycan-interacting compounds |
| WO2013161614A1 (ja) | 2012-04-27 | 2013-10-31 | コニカミノルタ株式会社 | 酵素処理工程を含むレクチンを用いた抗原検出方法 |
| US10222385B2 (en) | 2013-12-27 | 2019-03-05 | Konica Minolta, Inc. | Methods for discriminating between prostate cancer and a benign prostate-disease |
| WO2015097862A1 (ja) * | 2013-12-27 | 2015-07-02 | コニカミノルタ株式会社 | 診断用情報の分析方法およびそのためのキット |
| US9879087B2 (en) | 2014-11-12 | 2018-01-30 | Siamab Therapeutics, Inc. | Glycan-interacting compounds and methods of use |
| DK3218005T5 (da) | 2014-11-12 | 2024-10-14 | Seagen Inc | Glycan-interagerende forbindelser og anvendelsesfremgangsmåder |
| IL302822A (en) | 2015-11-12 | 2023-07-01 | Seagen Inc | Compounds interacting with glycans and methods of use |
| EP3541847A4 (en) | 2016-11-17 | 2020-07-08 | Seattle Genetics, Inc. | COMPOUNDS INTERACTING WITH GLYCANE AND METHODS OF USE |
| KR20240044544A (ko) | 2017-03-03 | 2024-04-04 | 씨젠 인크. | 글리칸-상호작용 화합물 및 사용 방법 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5660834A (en) | 1988-03-11 | 1997-08-26 | The Biomembrane Institute | Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with carbohydrate-carrier conjugates |
| PT969873E (pt) | 1997-03-27 | 2006-09-29 | Pasteur Institut | Hidrato de carbono glicopeptido antigene multiplo, vacina abrangendo o mesmo e seu uso |
| EP0996455B1 (en) | 1997-04-16 | 2009-12-16 | Sloan-Kettering Institute For Cancer Research | Alpha-o-linked glycoconjugates with clustered (2,6)-st epitopes, methods of preparation and uses thereof |
| WO2000059540A1 (en) * | 1999-04-05 | 2000-10-12 | Biocrystal Ltd. | Assay kits and methods for immune complex-mediated activation involving shed antigens |
| US20060150262A1 (en) * | 2003-02-05 | 2006-07-06 | Jadwiga Bienkowska | Novel mucin-like polypeptides |
| JP2008516637A (ja) * | 2004-10-20 | 2008-05-22 | ザ スクリップス リサーチ インスティテュート | 真正細菌へのｎ−アセチルガラクトサミンアミノ酸のインビボ部位特異的組込み |
-
2006
- 2006-01-13 AT AT06290091T patent/ATE509027T1/de not_active IP Right Cessation
- 2006-01-13 ES ES06290091T patent/ES2366552T3/es active Active
- 2006-01-13 EP EP06290091A patent/EP1808442B1/en not_active Not-in-force
- 2006-01-13 PL PL06290091T patent/PL1808442T3/pl unknown
- 2006-02-23 CA CA2631582A patent/CA2631582C/en not_active Expired - Fee Related
- 2006-02-23 JP JP2008549768A patent/JP5231247B2/ja not_active Expired - Fee Related
- 2006-02-23 WO PCT/EP2006/002577 patent/WO2007079783A1/en active Application Filing
- 2006-02-23 US US12/160,605 patent/US9657074B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007079783A1 (en) | 2007-07-19 |
| CA2631582C (en) | 2014-04-08 |
| EP1808442B1 (en) | 2011-05-11 |
| EP1808442A1 (en) | 2007-07-18 |
| JP5231247B2 (ja) | 2013-07-10 |
| JP2009523137A (ja) | 2009-06-18 |
| ES2366552T3 (es) | 2011-10-21 |
| CA2631582A1 (en) | 2007-07-19 |
| US20100272707A1 (en) | 2010-10-28 |
| ATE509027T1 (de) | 2011-05-15 |
| US9657074B2 (en) | 2017-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL1808442T3 (pl) | Enzymatyczna synteza glikokoniugatów mucyny na dużą skalę i ich zastosowanie immunogenne | |
| PT1928882E (pt) | (s)-n-metilnaltrexona, processo para a sua síntese e sua utilização farmacêutica | |
| PH12013502192A1 (en) | Antibodies against human angiopoietin 2 | |
| WO2005063820A3 (en) | Il-7 fusion proteins | |
| GB0619291D0 (en) | Altered antibodies | |
| BRPI1010637A2 (pt) | suplementos nutricionais orais compreendendo probióticos | |
| WO2009010877A3 (en) | Conjugate purification | |
| SG160329A1 (en) | Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli | |
| MX2010003574A (es) | Anticuerpos il-23. | |
| EA201070003A1 (ru) | Эпихлоргидрин, способ получения и применение | |
| TW201129381A (en) | Antibodies against human CSF-1R and uses thereof | |
| IL222787A0 (en) | Process for preparing nebivolol | |
| IL265947A (en) | Preparation of stansoporfin with a high degree of purification on a large scale | |
| ATE493893T1 (de) | Feste enymformulierungen und verfahren zu deren herstellung | |
| WO2011003965A3 (fr) | Dispositif de séparation linéaire douce d'une première pièce et d'une seconde pièce | |
| WO2008046865A3 (en) | Long-term feed - elderly | |
| BRPI0408848B8 (pt) | composições farmacêuticas de complexo de ciclodextrina-cladribina complexo, usos do referido complexo, bem como processos para a sua preparação | |
| NO20091140L (no) | Fremgangsmate for fremstilling av polyester nanokompositter | |
| BR0207447A (pt) | Polipeptìdeos e fragmentos de dna correspondentes de streptococcus pyogenes úteis como componentes de vacina | |
| WO2008155339A3 (en) | Labelling methods | |
| MY162125A (en) | A process for producing a biomass containing astaxanthin | |
| TH132857A (th) | องค์ประกอบโภชนาการ | |
| WO2007034183A3 (en) | Process for the preparation of 4-aminopyrazole derivatives | |
| DE602007009713D1 (en) | Cross-spot | |
| WO2008076490A3 (en) | Histophilus somni antigens, compositions and methods of use |